Abstract
Chronic ethanol consumption is a risk factor for several human cancers. A variety of mechanisms may contribute to this carcinogenic effect of alcohol including oxidative stress with the generation of reactive oxygen species (ROS), formed via inflammatory pathways or as byproducts of ethanol oxidation through cytochrome P4502E1 (CYP2E1). ROS may lead to lipidperoxidation (LPO) resulting in LPO-products such as 4-hydoxynonenal (4-HNE) or malondialdehyde. These compounds can react with DNA bases forming mutagenic and carcinogenic etheno-DNA adducts. Etheno-DNA adducts are generated in the liver (HepG2) cells over-expressing CYP2E1 when incubated with ethanol;and are inhibited by chlormethiazole. In liver biopsies etheno-DNA adducts correlated significantly with CYP2E1. Such a correlation was also found in the esophageal- and colorectal mucosa of alcoholics. Etheno-DNA adducts also increased in liver biopsies from patients with non alcoholic steatohepatitis (NASH). In various animal models with fatty liver either induced by high fat diets or genetically modified such as in the obese Zucker rat, CYP2E1 is induced and paralleled by high levels of etheno DNA-adducts which may be modified by additional alcohol administration. As elevation of adduct levels in NASH children were already detected at a young age, these lesions may contribute to hepatocellular cancer development later in life. Together these data strongly implicate CYP2E1 as an important mediator for etheno-DNA adduct formation, and this detrimental DNA damage may act as a driving force for malignant disease progression.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bardag-Gorce F, Oliva J, Dedes J, Li J, French BA, French SW (2009) Chronic ethanol feeding alters hepatocyte memory which is not altered by acute feeding. Alcohol Clin Exp Res 33(4):684–692
Bartsch H, Nair J (2005) Accumulation of lipid peroxidation-derived DNA lesions: potential lead markers for chemoprevention of inflammation-driven malignancies. Mutat Res 591(1–2):34–44
Bartsch H, Nair J (2014) Lipid peroxidation-derived DNA adduts and the role in inflammation-related carcinogenesis. In: Hiraku Y, Kawanishi S, Ohshima H (eds) Cancer and inflammation mechanisms chemical, biological and clinical aspects. Wiley, Hoboken, pp 61–74
Frank A, Seitz HK, Bartsch H et al (2004) Immunohistochemical detection of 1,N6-ethenodeoxyadenosine in nuclei of human liver affected by diseases predisposing to hepato-carcinogenesis. Carcinogenesis 25(6):1027–1031
Bartsch H (1999) Keynote address: exocyclic adducts as new risk markers for DNA damage in man. IARC Sci Publ 150:1–16
Bartsch H, Nair J (2004) Oxidative stress and lipid peroxidation-derived DNA-lesions in inflammation driven carcinogenesis. Cancer Detect Prev 28(6):385–391
Nair J, Srivatanakul P, Haas C et al (2010) High urinary excretion of lipid peroxidation-derived DNA damage in patients with cancer-prone liver diseases. Mutat Res 683(1–2):23–28
Nair J, Furstenberger G, Burger F et al (2000) Promutagenic etheno-DNA adducts in multistage mouse skin carcinogenesis: correlation with lipoxygenase-catalyzed arachidonic acid metabolism. Chem Res Toxicol 13(8):703–709
Marks F, Muller-Decker K, Furstenberger G (2000) A causal relationship between unscheduled eicosanoid signaling and tumor development: cancer chemoprevention by inhibitors of arachidonic acid metabolism. Toxicology 153(1–3):11–26
Williams CS, Luongo C, Radhika A et al (1996) Elevated cyclooxygenase-2 levels in min mouse adenomas. Gastroenterology 111(4):1134–1140
Williams MV, Lee SH, Pollack M et al (2006) Endogenous lipid hydroperoxide-mediated DNA-adduct formation in min mice. J Biol Chem 281(15):10127–10133
Schmid K, Nair J, Winde G et al (2000) Increased levels of promutagenic etheno-DNA adducts in colonic polyps of FAP patients. Int J Cancer 87(1):1–4
Linhart K, Bartsch H, Seitz HK (2014) The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts. Redox Biol 3:56–62
Linhart KB, Glassen K, Peccerella T et al (2015 Apr) The generation of carcinogenic etheno-DNA adducts in the liver of patients with nonalcoholic fatty liver disease. Hepatobiliary Surg Nutr 4(2):117–123
Winter CK, Segall HJ, Haddon WF (1986) Formation of cyclic adducts of deoxyguanosine with the aldehydes trans-4-hydroxy-2-hexenal and trans-4-hydroxy-2-nonenal in vitro. Cancer Res 46(11):5682–5686
Chung FL, Chen HJ, Nath RG (1996) Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adducts. Carcinogenesis 17(10):2105–2111
el Ghissassi F, Barbin A, Nair J et al (1995) Formation of 1,N6-ethenoadenine and 3,N4-ethenocytosine by lipid peroxidation products and nucleic acid bases. Chem Res Toxicol 8(2):278–283
Vaca CE, Wilhelm J, Harms-Ringdahl M (1988) Interaction of lipid peroxidation products with DNA. A Rev Mutat Res 195(2):137–149
Pryor WA, Porter NA (1990) Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyunsaturated fatty acids. Free Radic Biol Med 8(6):541–543
Blair IA (2008) DNA adducts with lipid peroxidation products. J Biol Chem 283(23):15545–15549
Sodum RS, Chung FL (1991) Stereoselective formation of in vitro nucleic acid adducts by 2,3-epoxy-4-hydroxynonanal. Cancer Res 51(1):137–143
Nair U, Bartsch H, Nair J (2007) Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adduct types and levels in humans. Free Radic Biol Med 43(8):1109–1120
Hiraku Y, Kawanishi S (2014) Role of nitrative DNA damage in inflammation related carcinogenesis. In: Ohshima H (ed) Cancer and INflammation mechanisms: chemical, biological, and chemical aspects. Wiley, Hoboken, pp 41–59
Eberle G, Barbin A, Laib RJ et al (1989) 1,N6-etheno-2′-deoxyadenosine and 3,N4-etheno-2′-deoxycytidine detected by monoclonal antibodies in lung and liver DNA of rats exposed to vinyl chloride. Carcinogenesis 10(1):209–212
Nair J, Nair UJ, Sun X et al (2010) Quantifying etheno-DNA adducts in human tissues, white blood cells, and urine by ultrasensitive (32)P-postlabeling and immunohistochemistry. Methods Mol Biol 682:189–205
Nair J, Barbin A, Guichard Y et al (1995) 1,N6-ethenodeoxyadenosine and 3,N4-ethenodeoxycytine in liver DNA from humans and untreated rodents detected by immunoaffinity/32P-postlabeling. Carcinogenesis 16(3):613–617
Nair J, Godschalk RW, Nair U et al (2011) Identification of 3,N(4)-etheno-5-methyl-2′-deoxycytidine in human DNA: a new modified nucleoside which may perturb genome methylation. Chem Res Toxicol 25(1):162–169
Barbin A (2000) Etheno-adduct-forming chemicals: from mutagenicity testing to tumor mutation spectra. Mutat Res 462(2–3):55–69
Bartsch H, Barbin A, Marion MJ et al (1994) Formation, detection, and role in carcinogenesis of ethenobases in DNA. Drug Metab Rev 26(1–2):349–371
Basu AK, Wood ML, Niedernhofer LJ et al (1993) Mutagenic and genotoxic effects of three vinyl chloride-induced DNA lesions: 1,N6-ethenoadenine, 3,N4-ethenocytosine, and 4-amino-5-(imidazol-2-yl)imidazole. Biochemistry 32(47):12793–12801
Pandya GA, Moriya M (1996) 1,N6-ethenodeoxyadenosine, a DNA adduct highly mutagenic in mammalian cells. Biochemistry 35(35):11487–11492
Palejwala VA, Rzepka RW, Simha D et al (1993) Quantitative multiplex sequence analysis of mutational hot spots. Frequency and specificity of mutations induced by a site-specific ethenocytosine in M13 viral DNA. Biochemistry 32(15):4105–4111
Moriya M, Zhang W, Johnson F et al (1994) Mutagenic potency of exocyclic DNA adducts: marked differences between Escherichia coli and simian kidney cells. Proc Natl Acad Sci U S A 91(25):11899–11903
Levine RL, Yang IY, Hossain M et al (2000) Mutagenesis induced by a single 1,N6-ethenodeoxyadenosine adduct in human cells. Cancer Res 60(15):4098–4104
Swenberg JA, Fedtke N et al (1992) Etheno adducts formed in DNA of vinyl chloride-exposed rats are highly persistent in liver. Carcinogenesis 13(4):727–729
Cheng KC, Preston BD, Cahill DS et al (1991) The vinyl chloride DNA derivative N2,3-ethenoguanine produces G–A transitions in Escherichia coli. Proc Natl Acad Sci U S A 88(22):9974–9978
Hu W, Feng Z, Eveleigh J et al (2002) The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. Carcinogenesis 23(11):1781–1789
European Association for the Study of the Liver (2012) EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol 57(2):399–420
Lieber CS (1999) Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968–1998)–a review. Alcohol Clin Exp Res 23(6):991–1007
Weltman MD, Farrell GC, Hall P et al (1998) Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 27(1):128–133
Oneta CM, Lieber CS, Li J et al (2002) Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase. J Hepatol 36(1):47–52
Lieber CS (2004) CYP2E1: from ASH to NASH. Hepatol Res 28(1):1–11
Lu Y, Wu D, Wang X et al (2010) Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice. Free Radic Biol Med 49(9):1406–1416
Lu Y, Zhuge J, Wang X et al (2008) Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice. Hepatology 47(5):1483–1494
Gouillon Z, Lucas D, Li J et al (2000) Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole. Proc Soc Exp Biol Med 224(4):302–308
Bradford BU, Kono H, Isayama F et al (2005) Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol-induced oxidative DNA damage in rodent liver. Hepatology 41(2):336–344
Morgan K, French SW, Morgan TR (2002) Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Hepatology 36(1):122–134
Butura A, Nilsson K, Morgan K et al (2009) The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model. J Hepatol 50(3):572–583
Wang Y, Millonig G, Nair J et al (2009 Aug) Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease. Hepatology 50(2):453–461
Millonig G, Wang Y, Homann N et al (2011) Ethanol-mediated carcinogenesis in the human esophagus implicates CYP2E1 induction and the generation of carcinogenic DNA-lesions. Int J Cancer 128(3):533–540
Köhler BC, Arslic-Schmitt T, Pecerella T et al (2016) Possible mechanisms of ethanol mediated colorectal carcinogenesis: the role of cytochrome P4502E1, etheno-DNA adducts and the anti-apoptotic protein Mcl-1. Alcohol Clin Exp Res 40(10):2094–2101
Chalasani N, Gorski JC et al (2003) Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology 37(3):544–50.r
Teufel U, Peccerella T, Engelmann G et al (2015) Detection of carcinogenic etheno-DNA adducts in children and adolescents with non-alcoholic steatohepatitis (NASH). Hepatobiliary Surg Nutr 4(6):426–435
Wang Y, Seitz H, Wang X (2010) Moderate alcohol consumption aggravates high-fat diet induced steatohepatitis in rats. Alcohol Clin Exp Res 34(3):567–573
Duly AM, Alani B, Huang EY et al (2015) Effect of multiple binge alcohol on diet-induced liver injury in a mouse model of obesity. Nutr Diabetes 5:e154
Seth D, Hogg PJ, Gorrell MD et al (2008) Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease. J Hepatol 48(4):614–627
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this paper
Cite this paper
Peccerella, T. et al. (2018). Chronic Ethanol Consumption and Generation of Etheno-DNA Adducts in Cancer-Prone Tissues. In: Vasiliou, V., Zakhari, S., Mishra, L., Seitz, H. (eds) Alcohol and Cancer. Advances in Experimental Medicine and Biology, vol 1032. Springer, Cham. https://doi.org/10.1007/978-3-319-98788-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-98788-0_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98787-3
Online ISBN: 978-3-319-98788-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)